Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Feb 28, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring how artificial intelligence (AI) can help diagnose Helicobacter pylori infection and early-stage stomach lesions using images taken during an upper endoscopy. Helicobacter pylori is a type of bacteria that can cause stomach issues, and early detection of any related lesions is important for treatment. The study will compare the AI's analysis of endoscopic images with results from a breath test and tissue samples to see how accurately the AI can identify these conditions.

To participate in this trial, you need to be between 20 and 80 years old and scheduled to undergo both a breath test and an endoscopy. Unfortunately, if you have had any kind of stomach surgery in the past, you won't be eligible to join. If you decide to participate, you can expect to have your endoscopic images reviewed by the AI system along with the standard tests, helping researchers understand how effective this technology could be in diagnosing stomach conditions. This study is currently looking for participants, so it’s a great opportunity to contribute to important medical research!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 20-80
• • 2. Scheduled urea breath test and endoscopy
• Exclusion Criteria:
• • 1. History of gastric surgery